All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
ATEA PHARMACEUTICALS, INC. Last Reported: 2/29/2024 Stock Symbol: AVIR

Business Address

225 FRANKLIN STREET
SUITE 2100
BOSTON , MA US 02110

Mailing Address

225 FRANKLIN STREET
SUITE 2100
BOSTON , MA US 02110
Phone Number: 857-204-8109 / State Incorporated: DE / Fiscal Year End 12 /31

Balance Sheet

Date 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022 6/30/2022 3/31/2022 12/31/2021 9/30/2021 6/30/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019 9/30/2019 6/30/2019 3/31/2019 12/31/2018 12/31/2017
Cash and Cash Equivalents $143,823,000.00 $137,886,000.00 $213,700,000.00 $183,255,000.00 $188,460,000.00 $176,410,000.00 $684,480,000.00 $705,545,000.00 $764,375,000.00 $839,660,000.00 $816,460,000.00 $850,117,000.00 $105,383,000.00 -- -- $21,661,000.00 $25,604,000.00 -- -- $34,492,000.00 --
Accounts Receivable Net Current -- -- -- -- -- $4,514,000.00 -- -- -- -- $50,000,000.00 -- -- -- -- -- -- -- -- -- --
Inventory -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Prepaid Expenses and Other Current Assets $12,349,000.00 $8,190,000.00 $12,764,000.00 $11,902,000.00 $14,213,000.00 $12,446,000.00 $4,971,000.00 $7,687,000.00 $8,028,000.00 $3,286,000.00 $4,650,000.00 $7,545,000.00 $3,030,000.00 -- -- $249,000.00 -- -- -- -- --
Total Current Assets $590,455,000.00 $603,316,000.00 $620,826,000.00 $632,390,000.00 $660,922,000.00 $681,935,000.00 $689,451,000.00 $713,232,000.00 $772,403,000.00 $842,946,000.00 $871,110,000.00 $863,477,000.00 $108,413,000.00 -- -- $21,910,000.00 -- -- -- -- --
Property Plant and Equipement $1,289,000.00 $1,393,000.00 $1,497,000.00 $1,601,000.00 $1,705,000.00 $1,810,000.00 $1,896,000.00 $762,000.00 $23,000.00 $26,000.00 $33,000.00 $48,000.00 $49,000.00 -- -- $41,000.00 -- -- -- -- --
Intangible Assets Net -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Goodwill -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Other Assets $1,396,000.00 $1,396,000.00 $1,396,000.00 $1,691,000.00 $1,494,000.00 -- -- -- $466,000.00 $532,000.00 $400,000.00 $107,000.00 $1,644,000.00 -- -- $122,000.00 -- -- -- -- --
Total Assets $594,968,000.00 $608,075,000.00 $626,028,000.00 $638,131,000.00 $666,708,000.00 $686,576,000.00 $694,338,000.00 $717,189,000.00 $772,892,000.00 $843,504,000.00 $871,543,000.00 $863,632,000.00 $110,106,000.00 -- -- $22,073,000.00 -- -- -- -- --
Accounts Payable $4,252,000.00 $395,000.00 $3,962,000.00 $700,000.00 $2,551,000.00 $1,118,000.00 $13,885,000.00 $3,657,000.00 $4,534,000.00 $22,190,000.00 $10,701,000.00 $60,000.00 $4,476,000.00 -- -- $548,000.00 -- -- -- -- --
Accrued Liabilities -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Current Liabilities $39,776,000.00 $26,345,000.00 $23,679,000.00 $19,949,000.00 $26,136,000.00 $23,389,000.00 $33,881,000.00 $37,305,000.00 $62,815,000.00 $262,052,000.00 $273,682,000.00 $315,831,000.00 $10,872,000.00 -- -- $2,530,000.00 -- -- -- -- --
Long Term Debt -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Additional Paid-in Capital -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Accumulated Other Comprehensive Loss $207,000.00 $-262,000.00 $-310,000.00 $-307,000.00 $-684,000.00 $-855,000.00 -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Accumulated Deficit $-195,835,000.00 $-156,671,000.00 $-123,529,000.00 $-95,346,000.00 $-59,879,000.00 $-25,448,000.00 $-17,382,000.00 $13,953,000.00 $56,030,000.00 $-61,102,000.00 $-32,908,000.00 $-65,160,000.00 $-85,816,000.00 -- -- $-54,213,000.00 -- -- -- -- --
Total Stockholders' Equity $555,192,000.00 $581,730,000.00 $602,349,000.00 $618,182,000.00 $640,572,000.00 $663,187,000.00 $660,457,000.00 $679,884,000.00 $710,077,000.00 $581,452,000.00 $597,861,000.00 $547,801,000.00 $-76,511,000.00 $-63,127,000.00 $-53,370,000.00 $-49,571,000.00 $-45,090,000.00 $-41,615,000.00 $-38,208,000.00 $-36,161,000.00 $-27,511,000.00
Controlling Interest in Subsidiaries -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Liabilities and Equity $594,968,000.00 $608,075,000.00 $626,028,000.00 $638,131,000.00 $666,708,000.00 $686,576,000.00 $694,338,000.00 $717,189,000.00 $772,892,000.00 $843,504,000.00 $871,543,000.00 $863,632,000.00 $110,106,000.00 -- -- $22,073,000.00 -- -- -- -- --

Statement of Operations

Date 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022 6/30/2022 3/31/2022 12/31/2021 9/30/2021 6/30/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019 9/30/2019 6/30/2019 3/31/2019 12/31/2018 12/31/2017
Total Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Cost of Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Gross Profit -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Research and Development $114,243,000.00 $79,198,000.00 $22,063,000.00 $28,954,000.00 $81,936,000.00 $54,396,000.00 $49,491,000.00 $29,633,000.00 $167,205,000.00 $43,019,000.00 $66,375,000.00 $38,023,000.00 $24,177,000.00 -- -- $10,170,000.00 $2,411,000.00 -- -- $6,675,000.00 --
Selling, General, and Administrative -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Operating Expenses $164,162,000.00 $40,785,000.00 $35,235,000.00 $41,569,000.00 $130,650,000.00 $90,751,000.00 $74,470,000.00 $42,175,000.00 $212,990,000.00 $54,958,000.00 $87,033,000.00 $59,663,000.00 $31,677,000.00 -- -- $14,608,000.00 $3,769,000.00 -- -- $9,477,000.00 --
Loss from Operations $-164,162,000.00 $-117,589,000.00 $-76,804,000.00 $-41,569,000.00 $-130,650,000.00 $-16,281,000.00 $-74,470,000.00 $-42,175,000.00 $138,377,000.00 $17,196,000.00 $39,343,000.00 $-11,030,000.00 $-17,629,000.00 -- -- $-14,608,000.00 $-9,859,000.00 -- -- $-9,477,000.00 --
Loss Before Income Taxes $-134,938,000.00 $-96,123,000.00 $-63,202,000.00 $-35,270,000.00 $-119,499,000.00 $-11,899,000.00 $-73,292,000.00 $-42,077,000.00 $138,590,000.00 $-22,094,000.00 $39,452,000.00 -- -- -- -- -- -- -- -- -- --
Earnings Per Share Basic $-1.63 $-0.40 $-0.34 $-0.43 $-1.39 $-0.98 $-0.88 $-0.51 $1.46 $-0.34 $0.39 -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Basic 83,389,750 83,374,328 83,399,377 83,332,397 83,245,385 83,231,146 83,217,223 83,176,408 82,820,037 82,815,636 82,662,019 -- -- -- -- -- -- -- -- -- --
Earnings Per Share Diluted $-1.63 $-0.40 $-0.76 $-0.43 $-1.39 $-0.10 $-0.88 $-0.51 $1.37 $0.05 $0.36 -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Diluted 83,389,750 83,399,769 83,361,398 83,332,397 83,245,385 83,231,146 83,257,591 83,176,408 88,249,243 82,815,636 88,683,767 -- -- -- -- -- -- -- -- -- --
Common Stock Shares Authorized 300,000,000 300,000,000 300,000,000 300,000,000 300,000,000 300,000,000 300,000,000 300,000,000 300,000,000 300,000,000 300,000,000 300,000,000 80,529,575 -- -- 53,070,161 -- -- -- -- --
Common Stock Shares Outstanding 83,435,513 83,435,513 83,399,377 83,399,377 83,287,639 83,287,639 83,257,591 83,257,591 83,102,730 83,047,079 82,776,937 82,436,937 10,109,847 -- -- 10,091,100 -- -- -- -- --
Common Stock Value $83,000.00 $83,000.00 $83,000.00 $83,000.00 $83,000.00 $83,000.00 $83,000.00 $83,000.00 $83,000.00 $83,000.00 $83,000.00 $82,000.00 $10,000.00 -- -- $10,000.00 -- -- -- -- --
Common Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -- -- $0.00 -- -- -- -- --
Payments Of Dividends Common Stock -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Shares Authorized 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 -- -- -- -- -- -- -- -- --
Preferred Stock Shares Outstanding -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Value -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -- -- -- $0.00 -- -- -- -- --
Share Price -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Copyright 2024 PursePoor.com